Document is current
Any future updates will be listed below
-
Authors
McCartney, Danielle http://orcid.org/0000-0002-7783-5220
Irwin, Christopher
Bawa, Zeeta
Palmer, Blake
Sahinovic, Ayshe
Delang, Nathan
Cox, Gregory R.
Desbrow, Ben
Lau, Namson S.
McGregor, Iain S.
-
Funding
Funding for this research was provided by:
The Lambert Initiative for Cannabinoid Therapeutics (The Lambert Initiative for Cannabinoid Therapeutics)
- License Information
-
More Information
Article History
Received: 13 February 2024
Accepted: 14 May 2024
First Online: 23 May 2024
Declarations
:
: The study was approved by Griffith University’s Human Research Ethics Committee (GU Ref No: 2023/253) and performed in accordance with the standards of ethics outlined in the Declaration of Helsinki.
: All participants provided written informed consent prior to enrolment (i.e., any information/data being obtained).
: D.M., Z.B., A.S. and I.S.M. receive salary support from the Lambert Initiative for Cannabinoid Therapeutics. D.M. has received consulting fees from Medicinal Cannabis Industry Australia (MCIA). I.S.M. has received consulting fees from MCIA and Janssen, and holds share options from Kinoxis Therapeutics.
